Literature DB >> 24868214

The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation.

Joo Yun Yang1, Jihei Cha1, So-Yeon Shim1, Su Jin Cho1, Eun Ae Park1.   

Abstract

PURPOSE: Eosinophilia is common in premature infants, and its incidence increases with a shorter gestation period. We investigated the clinical significance of eosinophilia in premature infants born at <34 weeks gestation.
METHODS: We analyzed the medical records of premature infants born at <34 weeks gestation who were admitted to the neonatal intensive care unit at Ewha Womans University Mokdong Hospital between January 2003 and September 2010. Eosinophilia was defined as an eosinophil percentage of >3% of the total leukocytes. Perinatal parameters and clinical parameters were also analyzed.
RESULTS: Of the 261 infants born at <34 weeks gestation, 22.4% demonstrated eosinophilia at birth. The eosinophil percentage peaked in the fourth postnatal week at 7.5%. The incidence of severe eosinophilia increased after birth up to the fourth postnatal week when 8.8% of all patients had severe eosinophilia. Severity of eosinophilia was positively correlated with a lower gestational age, birth weight, and Apgar score. Respiratory distress syndrome, bronchopulmonary dysplasia, nephrocalcinosis, intraventricular hemorrhage, and sepsis were associated with a higher eosinophil percentage. The eosinophil percentage was significantly higher in infants with bronchopulmonary dysplasia from the first postnatal week and the percentage was the highest in the fourth postnatal week, with the maximal difference being 4.1% (P<0.001).
CONCLUSION: Eosinophilia is common in premature infants and reaches peak incidence and severity in the fourth postnatal week. The eosinophil percentage was significantly higher in bronchopulmonary dysplasia patients from the first postnatal week. Severe eosinophilia was significantly associated with the incidence of bronchopulmonary dysplasia even after adjusting for other variables.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Eosinophilia; Premature infants

Year:  2014        PMID: 24868214      PMCID: PMC4030118          DOI: 10.3345/kjp.2014.57.4.171

Source DB:  PubMed          Journal:  Korean J Pediatr        ISSN: 1738-1061


  19 in total

1.  Relative eosinophilia and functional adrenal insufficiency in critically ill patients.

Authors:  A Beishuizen; I Vermes; B S Hylkema; C Haanen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

Review 2.  Eosinophilia.

Authors:  M E Rothenberg
Journal:  N Engl J Med       Date:  1998-05-28       Impact factor: 91.245

3.  Eosinophil cationic protein in tracheal aspirates of preterm infants with bronchopulmonary dysplasia.

Authors:  B Raghavender; J B Smith
Journal:  J Pediatr       Date:  1997-06       Impact factor: 4.406

Review 4.  Strategies for prevention of neonatal chronic lung disease.

Authors:  C H Cole; J M Fiascone
Journal:  Semin Perinatol       Date:  2000-12       Impact factor: 3.300

Review 5.  [Hypereosinophilia in premature newborn infants].

Authors:  M Fayon; J P Babin
Journal:  Pediatrie       Date:  1988

Review 6.  Eosinophils: structure and functions.

Authors:  P F Weller
Journal:  Curr Opin Immunol       Date:  1994-02       Impact factor: 7.486

7.  Eosinophil activation in preterm infants with lung disease.

Authors:  E Berggren Broström; M Katz-Salamon; J Lundahl; G Halldén; B Winbladh
Journal:  Acta Paediatr       Date:  2007-01       Impact factor: 2.299

8.  Eosinophilia in premature infants: relationship to weight gain.

Authors:  E L Gibson; Y Vaucher; J J Corrigan
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

9.  The pattern of eosinophilia in premature infants. A prospective study in premature infants using the absolute eosinophil count.

Authors:  A M Bhat; J W Scanlon
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

10.  Eosinophilia in newborn infants.

Authors:  L Patel; B Garvey; S Arnon; I A Roberts
Journal:  Acta Paediatr       Date:  1994-08       Impact factor: 2.299

View more
  4 in total

1.  Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants.

Authors:  Dan Zhou; Fang Shi; Ying Xiong; Min Zhou; Huajing Wan; Hanmin Liu
Journal:  Eur J Pediatr       Date:  2018-10-15       Impact factor: 3.183

2.  Impact and Clinical Implications of Prematurity on Adaptive Immune Development.

Authors:  Emma Idzikowski; Thomas J Connors
Journal:  Curr Pediatr Rep       Date:  2020-10-26

3.  Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death.

Authors:  Jegen Kandasamy; Claire Roane; Alexander Szalai; Namasivayam Ambalavanan
Journal:  Pediatr Res       Date:  2015-08-13       Impact factor: 3.756

4.  Invasive mechanical ventilation and biomarkers as predictors of bronchopulmonary dysplasia in preterm infants.

Authors:  Camila Piqui Nascimento; Larissa Prado Maia; Patrícia Terra Alves; Aline Teodoro de Paula; Jair Pereira Cunha Junior; Vânia Olivetti Steffen Abdallah; Daniela Marques de Lima Mota Ferreira; Luiz Ricardo Goulart; Vivian Mara Gonçalves de Oliveira Azevedo
Journal:  J Pediatr (Rio J)       Date:  2020-05-11       Impact factor: 2.990

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.